|
|
||||||||
1La Jolla Bioengineering Institute, La Jolla; 2Center for Perinatal Biology, Loma Linda University, Loma Linda; and 3University of California, San Diego, La Jolla, California
Submitted 6 December 2004 ; accepted in final form 9 July 2005
| ABSTRACT |
|---|
|
|
|---|
shear stress gradient; proliferation; recirculating flow; atherosclerosis
An established in vitro model used to simulate in vivo spatial patterns of flow separation, recirculation, and reattachment is the sudden expansion flow chamber (SEFC) (14, 27). By creating a sudden asymmetric expansion in the flow path of perfusing media across a cultured endothelial monolayer, the SEFC generates a large spatial gradient in shear stress over a relatively small region of a cultured endothelial monolayer. This high gradient is caused by flow separation. Near to the expansion step, flow recirculates in an eddy, whereas further downstream, the flow reforms to the regular parabolic profile. In between, there is a point of flow reattachment where shear stress is zero (stagnation point). When the flow of perfusing media is held constant, a stable recirculating flow pattern is generated over the same spatial region of a cultured monolayer (a spatial gradient in shear stress). With the sudden onset of flow, recirculating flow undergoes a distinct developmental phase of several hundred milliseconds in which the reattachment point moves out from the expansion step (9, 14). If flow is pulsatile, the reattachment point migrates back and forth across the cultured monolayer with each oscillatory cycle of flow. Cells directly beneath the migrating reattachment point experience a dramatic and rapid change in shear stress as the stagnation point passes above (a temporal gradient in shear stress). Therefore, both maximal temporal and spatial gradients can overlap each other in this in vitro model system. Detailed numerical analyses of the SEFC have shown that a negligible temporal change can be achieved in this model if the onset of flow is slowly ramped up over time (14). Given that temporal gradients have been shown to induce atherogenic phenotypes (13), this technique has proven to be a powerful tool to elucidate the mechanochemical coupling between fluid shear stress and the localization of atherosclerotic lesions.
Using the SEFC model, we (14, 28) have previously demonstrated temporal gradients in shear stress stimulate endothelial cell proliferation, whereas spatial gradients affect endothelial proliferation no differently from steady uniform shear stress. Given that the promitogenic extracellular signal-regulated kinases 1 and 2 (ERK1/2) pathway is a known shear responsive kinase and is rapidly and specifically activated by temporal gradients in fluid shear stress (2, 3, 25), it represents a likely mediator for the promitogenic effects of recirculating flow that we have previously reported. ERK1/2 is a member the mitogen-activated protein kinase (MAPK) conserved cascade of kinases that stimulate the phosphorylation of transcription factors and other targets in response to extracellular signals such as growth factors, cytokines, and fluid shear stress (29). The ERK1/2 pathway is thought to be primarily involved in the regulation of cell proliferation and differentiation (19), whereas other members of the MAPK family may also be important in the regulation of cell apoptosis and inflammation (16, 23). ERK1/2 is believed to mediate cell proliferation through the phosphorylation of other downstream proteins, one of which is retinoblastoma protein (Rb), which controls the cell cycle transition from G1 phase to S phase (19, 24).
The present studies examine the effect of temporal and spatial gradients on ERK1/2 activation and the resulting proliferation in the recirculating flow model system. The SEFC model was used to differentiate the effect of temporal gradients in shear from that of spatial gradients on ERK1/2 activation in primary human umbilical vein endothelial cells (HUVEC). The spatial distribution of ERK1/2-activated cells in the endothelial monolayer were identified via en face immunohistochemical staining for phospho-ERK1/2. Downstream from ERK1/2 activation, rates of HUVEC proliferation were determined with and without pretreatment with a specific inhibitor of the ERK1/2 pathway. We also isolated and examined temporal gradients using a conventional parallel-plate flow chamber (PPFC) and well-defined flow profiles.
| METHODS |
|---|
|
|
|---|
Flow experiments. Dulbecco's modified Eagle's medium (Irvine Scientific) supplemented with 2% fetal bovine serum (Hyclone), 0.5 U/ml penicillin, and 0.05 mg/ml streptomycin was used as the perfusing medium for all experimental procedures. All flow chambers and accompanying apparatus were maintained at 37°C throughout the experiment. Time-matched sham controls (slides mounted on flow chambers without flow) and static controls (undisturbed slides in Petri dishes) were performed for all experimental groups.
The SEFC was a modification of a chamber previously described (28). The ratio between the sudden-expansion step and the inflow channel was 2:1. HUVEC monolayers were subjected to 1 h of flow for ERK1/2 activation studies and 4 h of flow for HUVEC proliferation studies. One of two methods for the onset of flow was used: 1) ramped onset (a smooth ramped increase from 0 to 3.5 ml/s within 15 s), or 2) sudden onset (the initiation of fully established flow at 3.5 ml/s within 300 ms). The flow rate of 3.5 ml/s was calculated to produce a shear stress of 10 dyn/cm2 in the region of reestablished flow downstream from the reattachment point. The continuous flow of media through the SEFC was maintained with a constant hydrostatic pressure head flow loop apparatus (10). Ramped flow was manually controlled through a screw-type pinch valve (Flow-Rite, PV-9). Immediately after the completion of each specific flow profile, slides were removed from the SEFC and stained for ERK1/2 activation or HUVEC proliferation (see En face staining for ERK1/2 active cells).
The geometry of the conventional PPFC was identical to the SEFC but lacked the sudden expansion of the flow path. In the PPFC, confluent HUVEC monolayers on glass slides were subjected to one of the following three laminar flow profiles (see Fig. 3A): 1) impulse (3-s impulse of 10 dyn/cm2 followed by 10 min of no flow), 2) ramped transient (a smooth 15-s ramped increase from 0 to 10 dyn/cm2, sustained for 3 s, followed by a 15-s ramped decrease and 10 min of no flow), and 3) 1 Hz pulsatile (a repeated sequence of 0.5-s impulses of 10 dyn/cm2 at a frequency of 1 Hz sustained for 10 min). Perfusing medium was driven by a computer-controlled syringe pump (pump 22, Harvard Apparatus with a controlling PC). Immediately after the completion of each specific flow profile, slides were removed from the PPFC and stained for ERK1/2-activated cells (see En face staining for ERK1/2 active cells).
|
Immunofluorescent staining. Proliferating HUVEC were identified by using a commercially available in situ monoclonal antibody kit for the detection of bromodeoxyuridine (BrdU) incorporation into cellular DNA during DNA synthesis (Boehringer Mannheim). Immediately after exposure to flow in the SEFC or the PPFC, slides were quickly removed from the chamber and incubated at 37°C in medium 199-BrdU (10 fmol/l BrdU) for 22 h. Slides were fixed in 70% ethanol (in 50 mM glycine buffer, pH 2.0) and immunostained for BrdU incorporation. BrdU-positive cells were visualized under a fluorescence microscope (Nikon, Diaphot TMD). Proliferating cells were counted by eye within adjacent x100 HPF along the centerline of each slide. In the SEFC, each HPF was divided into 0.86-mm sections extending 9.46 mm downstream from the expansion point. In the PPFC, 20 HPF were counted for each slide.
Statistics. All experimental values are given as means ± SE. All reported values of n refer to the number of separate and independent experiments from multiple primary HUVEC cultures. Significant differences between means were calculated using a Student's t-test. The Wilcoxon test was used to test for a significant departure of the median from sham control. Statistical significance was taken at the P < 0.05 level.
| RESULTS |
|---|
|
|
|---|
Effect of flow onset in SEFC on ERK1/2 activation and HUVEC proliferation. The region extending 2.6 mm downstream from the point of expansion was taken to fully contain the spatial pattern of flow separation, recirculation, and reattachment. The region of reestablished unidirectional flow was taken to fully contain between 3.4 and 8.6 mm downstream from the expansion point.
All ERK1/2-positive cells were counted in each 0.86-mm section along the centerline of the slide and expressed as ERK1/2-positive cells per HPF. Within the region of recirculating flow, sudden onset of flow stimulated a significant (P < 0.05) peak 330% increase in ERK1/2-positive cells relative to the corresponding region of ramped onset (1.722.58 mm from expansion) (Fig. 1). This region closely correlates with the calculated location of flow reattachment and maximal temporal gradient for the 2:1 SEFC (14). Between the two onset profiles, ERK1/2-positive cells were not significantly different at corresponding locations within the region of unidirectional flow downstream from the reattachment point. Within the region of recirculation and in the absence of temporal gradients (ramped onset), spatial gradients in shear stress affected ERK1/2 activation no differently from steady shear stress. When cells were pretreated with U-0126 and then exposed to the sudden onset of flow in the SEFC, no ERK1/2-positive cells were identified along the centerline of the slide (data not shown).
|
|
HUVEC proliferation was expressed as percent increase in BrdU-positive nuclei above sham controls (Fig. 3C). No significant differences were observed in the level of proliferation between sham controls and static controls (data not shown). When HUVEC were exposed to continuous pulsatile flow at the frequency of 1 Hz sustained for 10 min, proliferation increased by 171 ± 9% (n = 4). When HUVEC were exposed to a single impulse of flow, proliferation increased 168 ± 6% (n = 4). No significant differences were observed in the level of proliferation between a 1-Hz pulsatile and a single impulse. The rate of BrdU incorporation in HUVEC treated with U-0126 and exposed to pulsatile and impulse flow was not significantly different from U-0126-treated sham controls (13 ± 13% and 3 ± 12%, respectively). Between sham controls treated with and without U-0126, rates of BrdU incorporation were not significantly different.
| DISCUSSION |
|---|
|
|
|---|
Through the utilization of two different flow systems (SEFC and PPFC), cells were exposed individually and specifically to flow with and without temporal and spatial gradients as well as combinations of the two. Consistent with our previous findings, when the onset of flow in the SEFC was sudden, both ERK1/2 activation (Fig. 1) and endothelial proliferation (Fig. 2) were significantly stimulated at the site of flow reattachment. Furthermore, when the onset of flow was slowly ramped up, ERK1/2 activation remained unstimulated within the same spatial region. Both onset flow profiles generate the same spatial gradient in shear stress (which is maximal at the site of flow reattachment). Thus further supporting previous studies suggesting that spatial gradients in shear stress affect endothelial proliferation no differently from steady uniform shear stress (28). In good agreement to patterns of ERK1/2 activation seen in the SEFC, in the PPFC where flow is uniform without spatial gradients, elevated ERK1/2 activation was only observed when HUVEC were exposed to temporal gradients (Fig. 3B).
ERK1/2 activation is regulated by the upstream enzyme MAPK/ERK kinase 1 and 2 (MEK1/2). ERK1/2 activation can be specifically blocked by the MEK1/2 inhibitor U-0126. In the current study, U-0126 was able to block all detectable ERK1/2 activation in both sham controls and by temporal gradients in shear. Previous studies using Western blot analysis quantification of ERK1/2 phosphorylation found that U-0126 was able to block the activation of ERK1/2 incurred by temporal gradients in shear, but not basal, ERK1/2 phosphorylation (18). Immunohistochemical staining for the spatial distribution of phospho-ERK1/2 is at least an order of magnitude less sensitive than Western blot detection. It is likely that basal ERK1/2 activation went undetected by the methodology employed in this study. This possibility is supported by the finding that BrdU incorporation was still observed 24 h after U-0126 treatment. However, BrdU incorporation in U-0126 treated controls was still significantly less than that observed for untreated controls.
The ultimate response of an endothelial cell to any flow pattern is a balance between the magnitudes of the atherogenic/mitogenic signal (temporal gradient) and the anti-atherogenic/anti-mitogenic (steady shear) (1, 2, 12, 20). In the SEFC, the relative contribution of steady versus dynamic components varies with the location and the geometry of the chamber and the duration of flow (14). With the sudden onset of flow in the SEFC, the entire HUVEC monolayer is exposed to some degree of a temporal gradient. The peak temporal gradient occurs between 1.72 and 2.58 mm. Once flow is established, although certain regions are exposed to flow recirculation, a significant steady shear stress component is present throughout the majority of the chamber. If flow remains steady, over time, the steady component suppresses the proliferative response to the temporal component. At the reattachment point, the mean wall shear stress within that region is very low to zero. Without steady flow, the effect of the temporal gradient generated during the onset of flow is preserved in this region. In vivo, where blood flow is pulsatile, the reattachment point oscillates along the vascular wall continually exposing the underlying endothelial monolayer to strong temporal gradients in shear stress. Given that no significant component of steady shear can be developed within the migrating reattachment point, this may lead to a spatially broader atherogenic stimulus in vivo than seen in the SEFC. For the ERK1/2 study in the SEFC, flow was limited to 1 h. Whereas in studies of BrdU incorporation in the SEFC, flow was stable for 4 h. Time-course studies identified 1 h as a balance between the reported time course for maximal ERK1/2 activation in response to temporal gradients (3) and the time required for the suppression of ERK1/2 activation by steady shear (data not shown).
In the PPFC, we confirmed previous findings that a single impulse of flow stimulates HUVEC proliferation as effectively as sustained pulsatile flow (Fig. 3C) (28). In sharp contrast to that finding, ERK1/2 activation in response to pulsatile flow was stimulated 620% above sham control, whereas a single impulse of flow stimulated only 166% (Fig. 3B). Given that the elevation in ERK1/2 phosphorylation in response to pulsatile flow does not lead to a greater mitogenic response (in comparison to a single impulse), it is likely that ERK1/2 activation is far in excess of threshold levels required to stimulate a proliferative response. The transition from G1 phase to S phase of the cell cycle requires the phosphorylation of Rb at multiple sites. ERK1/2 is an upstream mediator of Rb phosphorylation (6, 8, 18). Hyperphosphorylation of Rb causes the release of the E2F transcription factor and commits the cell into the S phase (11). Once a cell has entered the S phase, continued ERK1/2 activity will not stimulate additional cell proliferation. Therefore, the increased phosphorylation of ERK1/2 in response to pulsatile flow may further indicate the exquisite sensitivity of ERK1/2 to temporal gradients in fluid shear stress. In further support of ERK1/2 as a critical signaling molecule mediating shear-dependent proliferation response, when cells were pretreated with U-0126, neither a single impulse of flow or sustained pulsatile flow resulted in increased rates of HUVEC proliferation.
The present study was designed to elucidate the upstream signal transduction pathway leading to endothelial proliferation in atherosclerosis-susceptible regions of the vasculature. The biophysical mechanism by which large temporal gradients in shear stress stimulate ERK1/2 activation remains to be determined. Rapid mechanochemical signal transduction during the sudden onset of flow similar to that observed in this study has previously been reported (13), where specific mitogenic G protein activation occurs within 1 s. When considering these findings, it is important to bear in mind that atherosclerosis is a protracted and multifactorial disease that involves many circulating blood elements, hemodynamic forces, and a complex cascade of molecular events within the endothelium and the arterial wall.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. R White and J. A Frangos The shear stress of it all: the cell membrane and mechanochemical transduction Phil Trans R Soc B, August 29, 2007; 362(1484): 1459 - 1467. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |